Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Total 13F shares
-
98,465,392
-
Share change
-
+7,879,570
-
Total reported value
-
$2,312,773,060
-
Put/Call ratio
-
93%
-
Price per share
-
$23.50
-
Number of holders
-
190
-
Value change
-
+$189,519,484
-
Number of buys
-
112
-
Number of sells
-
60
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q4 2019
As of 31 Dec 2019,
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) was held by
190 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
98,465,392 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, VANGUARD GROUP INC, FMR LLC, BAKER BROS. ADVISORS LP, BlackRock Inc., TANG CAPITAL MANAGEMENT LLC, JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, ArrowMark Colorado Holdings LLC, and Clearbridge Investments, LLC.
This page lists
190
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.